Hepatitis C News
Most Popular Hepatitis C Story
Docs back Viread for hepatitis B
Analysts are chatting up Gilead Science's HIV drug Viread as a treatment for hepatitis B. Currently under FDA review for that indication, Viread already has the backing of four out of five doctors, Read more...
Latest Headlines
- December 21, 2011
- December 15, 2011
- October 28, 2011
- October 12, 2011
- October 7, 2011
- September 27, 2011
- September 21, 2011
- September 1, 2011
- August 19, 2011
- August 1, 2011
- July 29, 2011
- July 25, 2011
- June 29, 2011
- May 23, 2011
- May 16, 2011
- April 5, 2011
- May 29, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
